Skip to main content

BIO-PATH HOLDINGS INC

For the period ended Jun 30, 2024. Filed Aug 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 14, 2024

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In thousands)

​​​​​​​
​ · ​ · Six Months Ended June 30,
​ · ​ · 2024 · ​ · 2023
Cash flow from operating activities · ​ · ​
​ · ​ · ​
Net loss​$(5,026)​$(9,507)
​​​
Adjustments to reconcile net loss to net cash used in operating activities​​
​​​
Stock-based compensation​311​376
Amortization of right of use assets​51​47
Depreciation​28​44
Change in fair value of warrant liability​​(1,701)​​—
(Increase) decrease in operating assets​​
Prepaid drug product​358​2,518
Other current assets​619​(102)
Increase (decrease) in operating liabilities​​
Accounts payable and accrued expenses​1,152​(263)
Lease liabilities​(58)​(53)
​​​
Net cash used in operating activities​(4,266)​(6,940)
​​​
Cash flow from financing activities​​
​​​
Net proceeds from sale of common stock​7,220​—
​​​​​
Net cash provided by financing activities​7,220​—
​​​
Net increase (decrease) in cash​2,954​(6,940)
​​​
Cash, beginning of period​1,052​10,384
​​​
Cash, end of period​$4,006​$3,444
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.